In vivo analyses also validated that FOXP3-mediated induction of miR-146a resulted in the downregulation of IRAK1 and TRAF6 and subsequently inhibited NF-κB activation, thus leading to tumor suppression in breast cancer cells. Here, TRAF6 is linked to neoplasm.